ANIP — ANI Pharmaceuticals Share News
0.000.00%
Last trade - 00:00- $1.92bn
- $2.21bn
- $883.37m
ANI Pharmaceuticals Q1 revenue rises 21%, adjusted EPS beats estimates
Brief: ANI Pharmaceuticals Q1 Adjusted EPS USD 2.05 Vs. IBES Estimate USD 1.3
U.S. STOCKS ON THE MOVE-Conagra, Oracle, Replimune
U.S. STOCKS ON THE MOVE-Allogene Therapeutics, Adobe, Williams-Sonoma
ANI Pharmaceuticals rises on US launch of generic epilepsy drug
U.S. STOCKS ON THE MOVE-Meta, Legence, Chegg
U.S. STOCKS ON THE MOVE-Hims & Hers, Chewy, Longeveron
U.S. STOCKS ON THE MOVE-Delta, Levi's, banks
Brief: Ani Pharmaceuticals Announces FDA Approval And Launch Of Isosorbide Mononitrate Tablet
U.S. STOCKS ON THE MOVE-Delta, GATX, Humana
ANI Pharmaceuticals jumps after launching generic heart drug
U.S. STOCKS ON THE MOVE-Talen Energy, Applied Optoelectronics, oil companies
U.S. STOCKS ON THE MOVE-Oil companies, Arlo Technologies, AES
U.S. STOCKS ON THE MOVE-Netflix, Dell, Autodesk
ANI Pharma rises after quarterly results beat estimates
ANI Pharma Q4 profit beats on rare disease, generics growth; reaffims forecast
Brief: ANI Pharmaceuticals Announces Board Transition
U.S. STOCKS ON THE MOVE-Akamai Technologies, Enbridge, KKR
U.S. STOCKS ON THE MOVE-Novo Nordisk, Block, Peloton Interactive